MalarVx, Inc.
Biotechnology company · Seattle, Washington, United States
MalarVx, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2012. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $447,450 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $1.1 million sold in a notice filed in 2017.
MalarVx at a glance
What does MalarVx do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $447,450 in total (2020). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $1.1 million sold (2017).
Frequently asked questions about MalarVx
Where is MalarVx headquartered?
MalarVx, Inc. is headquartered in Seattle, Washington, United States.
What does MalarVx do?
MalarVx, Inc. is a biotechnology company.
When was MalarVx founded?
The earliest incorporation on record for MalarVx, Inc. is in 2012, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences